Cargando…

Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram

PURPOSE Radiomics can be used to determine the prognosis of gastric cancer (GC). The objective of this study was to predict the disease-free survival (DFS) after GC surgery based on computed tomography-enhanced images combined with clinical features. METHODS Clinical, imaging, and pathological data...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Shuguang, Miao, Zhongchang, Zhou, Ying, Xu, Chunling, Zhang, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Radiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682589/
https://www.ncbi.nlm.nih.gov/pubmed/36097638
http://dx.doi.org/10.5152/dir.2022.211034
_version_ 1784834881991213056
author Shi, Shuguang
Miao, Zhongchang
Zhou, Ying
Xu, Chunling
Zhang, Xue
author_facet Shi, Shuguang
Miao, Zhongchang
Zhou, Ying
Xu, Chunling
Zhang, Xue
author_sort Shi, Shuguang
collection PubMed
description PURPOSE Radiomics can be used to determine the prognosis of gastric cancer (GC). The objective of this study was to predict the disease-free survival (DFS) after GC surgery based on computed tomography-enhanced images combined with clinical features. METHODS Clinical, imaging, and pathological data of patients who underwent gastric adenocarcinoma resection from June 2015 to May 2019 were retrospectively analyzed. The primary outcome was DFS. Radiomics features were selected using Least Absolute Shrinkage and Selection Operator algorithm and converted into the Rad-score. A nomogram was constructed based on the Rad-score and other clinical factors. The Rad-score and nomogram were validated in the training and validation groups. Results Totally, 179 patients were randomly divided into the training (n = 124) and validation (n = 55) groups. In the training group, validation group, and overall population, the Rad-score could be divided into categories indicating low, moderate, and high risk of recurrence, metastasis, or death; all risk categories showed a significant difference between the training, validation, and overall population groups (all P < .001). Positive lymph nodes (hazard ratio (HR) = 3.07, 95% CI: 1.52-6.23, P = .002), cancer antigen-125 (HR = 3.24, 95% CI: 1.54-6.80, P = .002), and the Rad-score (HR = 0.73, 95% CI: 0.61-0.87, P < .001) were independently associated with DFS. These 3 variables were used to construct a nomogram. In the training group, the areas under the curve at 3 years were 0.758 and 0.776 for the Rad-score and the nomogram, respectively, while they were both 1.000 in the validation group. The net benefit rate was analyzed using a decision curve in the training and validation groups, and the nomogram was superior to the single Rad-score. CONCLUSION Rad-score is an independent factor for DFS after gastrectomy for GC. The nomogram established in this study could be an effective tool for the clinical prediction of DFS after gastrectomy.
format Online
Article
Text
id pubmed-9682589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish Society of Radiology
record_format MEDLINE/PubMed
spelling pubmed-96825892022-12-02 Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram Shi, Shuguang Miao, Zhongchang Zhou, Ying Xu, Chunling Zhang, Xue Diagn Interv Radiol Original Article PURPOSE Radiomics can be used to determine the prognosis of gastric cancer (GC). The objective of this study was to predict the disease-free survival (DFS) after GC surgery based on computed tomography-enhanced images combined with clinical features. METHODS Clinical, imaging, and pathological data of patients who underwent gastric adenocarcinoma resection from June 2015 to May 2019 were retrospectively analyzed. The primary outcome was DFS. Radiomics features were selected using Least Absolute Shrinkage and Selection Operator algorithm and converted into the Rad-score. A nomogram was constructed based on the Rad-score and other clinical factors. The Rad-score and nomogram were validated in the training and validation groups. Results Totally, 179 patients were randomly divided into the training (n = 124) and validation (n = 55) groups. In the training group, validation group, and overall population, the Rad-score could be divided into categories indicating low, moderate, and high risk of recurrence, metastasis, or death; all risk categories showed a significant difference between the training, validation, and overall population groups (all P < .001). Positive lymph nodes (hazard ratio (HR) = 3.07, 95% CI: 1.52-6.23, P = .002), cancer antigen-125 (HR = 3.24, 95% CI: 1.54-6.80, P = .002), and the Rad-score (HR = 0.73, 95% CI: 0.61-0.87, P < .001) were independently associated with DFS. These 3 variables were used to construct a nomogram. In the training group, the areas under the curve at 3 years were 0.758 and 0.776 for the Rad-score and the nomogram, respectively, while they were both 1.000 in the validation group. The net benefit rate was analyzed using a decision curve in the training and validation groups, and the nomogram was superior to the single Rad-score. CONCLUSION Rad-score is an independent factor for DFS after gastrectomy for GC. The nomogram established in this study could be an effective tool for the clinical prediction of DFS after gastrectomy. Turkish Society of Radiology 2022-09-01 /pmc/articles/PMC9682589/ /pubmed/36097638 http://dx.doi.org/10.5152/dir.2022.211034 Text en © Copyright 2022 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
Shi, Shuguang
Miao, Zhongchang
Zhou, Ying
Xu, Chunling
Zhang, Xue
Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram
title Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram
title_full Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram
title_fullStr Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram
title_full_unstemmed Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram
title_short Radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram
title_sort radiomics signature for predicting postoperative disease-free survival of patients with gastric cancer: development and validation of a predictive nomogram
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682589/
https://www.ncbi.nlm.nih.gov/pubmed/36097638
http://dx.doi.org/10.5152/dir.2022.211034
work_keys_str_mv AT shishuguang radiomicssignatureforpredictingpostoperativediseasefreesurvivalofpatientswithgastriccancerdevelopmentandvalidationofapredictivenomogram
AT miaozhongchang radiomicssignatureforpredictingpostoperativediseasefreesurvivalofpatientswithgastriccancerdevelopmentandvalidationofapredictivenomogram
AT zhouying radiomicssignatureforpredictingpostoperativediseasefreesurvivalofpatientswithgastriccancerdevelopmentandvalidationofapredictivenomogram
AT xuchunling radiomicssignatureforpredictingpostoperativediseasefreesurvivalofpatientswithgastriccancerdevelopmentandvalidationofapredictivenomogram
AT zhangxue radiomicssignatureforpredictingpostoperativediseasefreesurvivalofpatientswithgastriccancerdevelopmentandvalidationofapredictivenomogram